Theresa G. Wingrove

2020

In 2020, Theresa G. Wingrove earned a total compensation of $1.3M as Senior Vice President, Regulatory Affairs and Quality at ImmunoGen, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,021
Option Awards$718,744
Salary$409,667
Other$5,517
Total$1,266,949

Wingrove received $718.7K in option awards, accounting for 57% of the total pay in 2020.

Wingrove also received $133K in non-equity incentive plan, $409.7K in salary and $5.5K in other compensation.

Rankings

In 2020, Theresa G. Wingrove's compensation ranked 7,597th out of 13,090 executives tracked by ExecPay. In other words, Wingrove earned more than 42.0% of executives.

ClassificationRankingPercentile
All
7,597
out of 13,090
42nd
Division
Manufacturing
3,202
out of 5,621
43rd
Major group
Chemicals And Allied Products
1,291
out of 2,254
43rd
Industry group
Drugs
1,117
out of 1,954
43rd
Industry
Pharmaceutical Preparations
833
out of 1,459
43rd
Source: SEC filing on April 28, 2021.

Wingrove's colleagues

We found four more compensation records of executives who worked with Theresa G. Wingrove at ImmunoGen in 2020.

2020

Mark Enyedy

ImmunoGen

Chief Executive Officer

2020

Anna Berkenblit

ImmunoGen

Chief Medical Officer

2020

Susan Altschuller

ImmunoGen

Chief Financial Officer

2020

Stacy Coen

ImmunoGen

Senior Vice President and Chief Business Officer

News

In-depth

You may also like